NAGE · Niagen Bioscience, Inc. · Fails to Deliver
$2.50
+0.06 (+2.46%)
At close · Oct 27
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$193.07M
Shares
79.13M
Volume · Oct 27
473.48K
Avg daily vol (3M)
546.87K
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-09-30 | 1,256 | $2.95 | $3,705 |
| 2026-09-28 | 1,283 | $3.05 | $3,913 |
| 2026-09-23 | 11,930 | $3.09 | $36,864 |
| 2026-09-18 | 827 | $2.99 | $2,473 |
| 2026-09-14 | 320 | $3.04 | $973 |
| 2026-08-27 | 61 | $3.30 | $201 |
| 2026-08-25 | 1 | $3.21 | $3 |
| 2026-08-04 | 3,081 | $3.53 | $10,876 |
| 2026-07-28 | 273 | $3.23 | $882 |
Showing 1–9 of 9 settlements
Key facts
CIK
1386570
CUSIP
171077407
13F (30d)
17 filings
16 filers
Visit website
Investor relations